Katalog der Deutschen Nationalbibliothek

Gesamter Bestand

Musikarchiv

Exilsammlungen

Buchmuseum

Suchformular zurücksetzen

Expertensuche ?

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

Die Lesesäle für Geisteswissenschaften, Naturwissenschaften, der Alte Lesesaal Technik und der Anne-Frank-Shoah-Lesesaal in Leipzig schließen am 04.02.2026 wegen einer Veranstaltung bereits um 15 Uhr. Die weiteren Lesesäle sowie die Servicetheke sind zu den regulären Zeiten geöffnet. //
The humanities reading room, the natural science reading room, the old technology reading room and the reading room of the Anne-Frank-Shoah-Library will close at 15:00 on 4 February 2026 due to an event. The other reading rooms and the service desk will be open during regular hours.

Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

8951 - 8960 von 9948

	8951	Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: a phase 1 trial with a randomized, placebo-controlled design Enthalten in Virology journal Bd. 21, 20.12.2024, Nr. 1, date:12.2024: 1-9
	8952	Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial Enthalten in Arthritis Research & Therapy Bd. 14, 8.1.2012, Nr. 1, date:2.2012: 1-10
	8953	Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, a Non-peptide GnRH Antagonist in Premenopausal Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study Enthalten in Clinical pharmacokinetics Bd. 62, 14.10.2023, Nr. 12, date:12.2023: 1739-1748
	8954	Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone receptor antagonist, in healthy men: a randomized, double-blind, placebo-controlled phase 1 study Enthalten in BMC medicine Bd. 21, 3.4.2023, Nr. 1, date:12.2023: 1-10
	8955	Safety, Pharmacokinetics, Serum Neutralizing Titers, and Immunogenicity of Adintrevimab, a Monoclonal Antibody Targeting SARS-CoV-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Dose-escalation Study in Healthy Adults Enthalten in Infectious diseases and therapy Bd. 12, 25.4.2023, Nr. 5, date:5.2023: 1365-1377
	8956	Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study Enthalten in Journal of translational medicine Bd. 16, 6.3.2018, Nr. 1, date:12.2018: 1-13
	8957	Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study Enthalten in Alzheimer's research & therapy Bd. 10, 12.10.2018, Nr. 1, date:12.2018: 1-14
	8958	Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial Enthalten in Alzheimer's research & therapy Bd. 10, 29.1.2018, Nr. 1, date:12.2018: 1-13
	8959	Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial Enthalten in Diabetologia Bd. 67, 19.2.2024, Nr. 5, date:5.2024: 811-821
	8960	Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial Enthalten in BMC gastroenterology Bd. 18, 5.1.2018, Nr. 1, date:12.2018: 1-17